Human Choline Acetyltransferase/ChAT Antibody Summary
Ala2-Pro630
Accession # NP_066266
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Detection of Human Choline Acetyltransferase/ChAT by Dot Blot Detection and characterization of extracellular ChAT protein in human plasma and CSF.(a) Dot-blot analysis of nine different pooled CSF samples using two different antibodies. (b) The relative amount of ChAT in plasma or CSF, compared to brain homogenates (BH) of AD or control. At 16-fold dilutions, the immunosignals are much stronger in plasma and CSF compared to BH. This demonstrates the relative abundance of the ChAT protein in extracellular fluids. (c) Western-blot characterization of molecular form of ChAT in plasma, CSF and BH. The major detected protein band (*) in the BHs corresponds to a ChAT protein with a Mw of ∼65 kDa. In addition, there are several detected heavier molecular forms of ChAT in the CSF. All samples were loaded on one gel. Note also that the amount of the ∼65 kDa ChAT was so high in plasma that it distorted the gel downward. (d–g) Combinatorial sandwich ELISA results for identification of extracellular ChAT using three different antibody pairs for recombinant human ChAT (rhChAT), and a pooled plasma sample (g) calibrated for ChAT protein concentration using the rhChAT and ELISA setup in (f). (h) Further characterization of the molecular forms of CSF ChAT in consecutive fractions of pooled AD CSF samples separated by sucrose-density gradient technique, and the subsequent quantification of ChAT by sandwich ELISA. The graph represents the average of nine different pooled CSF. This independent analysis provides an identical pattern of molecular forms detected by Western analysis. Due to lack of prior reports, we used analogous terminology, which is used for the counteracting cholinergic enzymes, AChE and BuChE, that is, Gn, where n denotes the number of globular subunits in each detected molecular form of ChAT in CSF. The molecular weights are calculated based on the known Mw of two internal standard proteins. In all dot-blot analyses, 2 µL of each sample (neat or diluted) was used. In the Western blot analysis, each lane was loaded with 15 µL of a mixture, containing 10 µL of sample (neat or diluted) and 5 µL of a 6x concentrated reducing Laemmli loading buffer. All ChAT protein quantifications were done with the ELISA antibody pair’s combination in (g). Anti-ChAT antibodies: RP = rabbit polyclonal antibody (Ab), BGP = biotin-labeled goat polyclonal Ab, MAB = mouse monoclonal Ab. Image collected and cropped by CiteAb from the following publication (https://dx.plos.org/10.1371/journal.pone.0065936), licensed under a CC-BY license. Not internally tested by R&D Systems.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: Choline Acetyltransferase/ChAT
ChAT catalyzes the production of the neurotransmitter acetylcholine (Ach), which is required for cholinogenic neuron communication. It serves as a marker for functional cholinogenic neurons in the central and peripheral nervous systems. At least six ChAT mRNAs encoding 69 kDa, 82 kDa and 74 kDa ChAT proteins have been identified. Compared to the 82 kDa form, 69 kDa ChAT lacks the N‑terminal 118 amino acid extension containing a nuclear localization signal. As a result the 69 kDa ChAT is primarily localized to the cytoplasm. Human 69 kDa ChAT shares 86% amino acid sequence identity with the mouse or rat ChAT.
Product Datasheets
Citations for Human Choline Acetyltransferase/ChAT Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
4
Citations: Showing 1 - 4
Filter your results:
Filter by:
-
Transplantable human motor networks as a neuron-directed strategy for spinal cord injury
Authors: Zachary T. Olmsted, Cinzia Stigliano, Annalisa Scimemi, Tatiana Wolfe, Jose Cibelli, Philip J. Horner et al.
iScience
-
Regulated Extracellular Choline Acetyltransferase Activity— The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway
Authors: Swetha Vijayaraghavan, Azadeh Karami, Shahin Aeinehband, Homira Behbahani, Alf Grandien, Bo Nilsson et al.
PLoS ONE
-
Visual hallucinations in Alzheimer's disease do not seem to be associated with chronic hypoperfusion of to visual processing areas V2 and V3 but may be associated with reduced cholinergic input to these areas
Authors: LI Sinclair, A Kumar, T Darreh-Sho, S Love
Alzheimers Res Ther, 2019-09-12;11(1):80.
Species: Human
Sample Types: Tissue Homogenates
Applications: ELISA Capture -
CSF Cholinergic Index, a New Biomeasure of Treatment Effect in Patients With Alzheimer’s Disease
Authors: Azadeh Karami, Maria Eriksdotter, Ahmadul Kadir, Ove Almkvist, Agneta Nordberg, Taher Darreh-Shori
Frontiers in Molecular Neuroscience
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human Choline Acetyltransferase/ChAT Antibody
There are currently no reviews for this product. Be the first to review Human Choline Acetyltransferase/ChAT Antibody and earn rewards!
Have you used Human Choline Acetyltransferase/ChAT Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image